Jianling Du

4.1k total citations
51 papers, 1.2k citations indexed

About

Jianling Du is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Jianling Du has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Molecular Biology and 8 papers in Nutrition and Dietetics. Recurrent topics in Jianling Du's work include Selenium in Biological Systems (8 papers), Thyroid Disorders and Treatments (7 papers) and Diabetes Treatment and Management (6 papers). Jianling Du is often cited by papers focused on Selenium in Biological Systems (8 papers), Thyroid Disorders and Treatments (7 papers) and Diabetes Treatment and Management (6 papers). Jianling Du collaborates with scholars based in China, United States and United Kingdom. Jianling Du's co-authors include Qian Xing, Lili Men, Ying Ba, Hao Wang, Weiping Teng, Zhongyan Shan, Jinyuan Mao, Chenling Fan, Zhengnan Gao and Xiaochen Xie and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Biochemical and Biophysical Research Communications.

In The Last Decade

Jianling Du

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianling Du China 19 622 264 239 170 156 51 1.2k
Oleg Tsuprykov Germany 22 403 0.6× 216 0.8× 174 0.7× 103 0.6× 90 0.6× 33 1.2k
Marina Shargorodsky Israel 19 296 0.5× 229 0.9× 64 0.3× 62 0.4× 150 1.0× 54 1.2k
Tiziana Filardi Italy 19 261 0.4× 316 1.2× 101 0.4× 227 1.3× 58 0.4× 49 1.3k
Carl V. Felton United Kingdom 14 716 1.2× 155 0.6× 296 1.2× 217 1.3× 84 0.5× 24 1.5k
Tiina Solakivi Finland 20 396 0.6× 205 0.8× 100 0.4× 49 0.3× 161 1.0× 44 1.5k
Yong‐Ki Min South Korea 25 955 1.5× 449 1.7× 64 0.3× 67 0.4× 48 0.3× 101 2.0k
Clarice Kazue Fujihara Brazil 28 321 0.5× 563 2.1× 130 0.5× 61 0.4× 151 1.0× 63 2.2k
Antonysunil Adaikalakoteswari United Kingdom 20 214 0.3× 371 1.4× 232 1.0× 191 1.1× 141 0.9× 39 1.6k
P. Fumelli Italy 19 379 0.6× 237 0.9× 53 0.2× 41 0.2× 100 0.6× 52 1.1k
E. Delvin Canada 20 114 0.2× 274 1.0× 158 0.7× 45 0.3× 168 1.1× 43 1.1k

Countries citing papers authored by Jianling Du

Since Specialization
Citations

This map shows the geographic impact of Jianling Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianling Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianling Du more than expected).

Fields of papers citing papers by Jianling Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianling Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianling Du. The network helps show where Jianling Du may publish in the future.

Co-authorship network of co-authors of Jianling Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jianling Du. A scholar is included among the top collaborators of Jianling Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianling Du. Jianling Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xianghai, et al.. (2023). The association between self-monitoring of blood glucose and HbA1c in type 2 diabetes. Frontiers in Endocrinology. 14. 1056828–1056828. 3 indexed citations
2.
Men, Lili, Junjie Yao, Yu Li, et al.. (2022). Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance. Cell Death and Disease. 13(3). 275–275. 29 indexed citations
3.
Wang, Zinan, Yu Li, Junjie Yao, et al.. (2021). Selenoprotein S attenuates high glucose and/or ox-LDL-induced endothelium injury by regulating Akt/mTOR signaling and autophagy. The International Journal of Biochemistry & Cell Biology. 141. 106111–106111. 7 indexed citations
4.
Li, Suying, Zhe Li, Rui Wang, et al.. (2020). Effects of Saccharides from Arctium lappa L. Root on FeCl3-Induced Arterial Thrombosis via the ERK/NF-κB Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2020. 1–11. 8 indexed citations
5.
Yu, Hao, Junjie Yao, Lili Men, et al.. (2020). Selenoprotein S attenuates endothelial dysfunction in a diabetic vascular chip. Experimental Gerontology. 137. 110963–110963. 9 indexed citations
6.
Wang, Hao, Ying Ba, Qian Xing, & Jianling Du. (2019). Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis. BMJ Open. 9(1). e024067–e024067. 136 indexed citations
7.
Peng, Shiqiao, Jinyuan Mao, Xiulan Xie, et al.. (2019). Association between iodine intake and thyroid autoantibodies: a cross-sectional study of 7073 early pregnant women in an iodine-adequate region. Journal of Endocrinological Investigation. 43(1). 43–51. 22 indexed citations
8.
Wang, Rui, Li Wang, Jinlong He, et al.. (2019). Specific Inhibition of CYP4A Alleviates Myocardial Oxidative Stress and Apoptosis Induced by Advanced Glycation End-Products. Frontiers in Pharmacology. 10. 876–876. 10 indexed citations
9.
Men, Lili, et al.. (2018). Selenoprotein S protects against adipocyte death through mediation of the IRE1α-sXBP1 pathway. Biochemical and Biophysical Research Communications. 503(4). 2866–2871. 12 indexed citations
10.
Men, Lili, Junjie Yao, Yang Yu, et al.. (2017). Atherosclerosis associated with dynamic inflammation changes after multifactorial intervention in short-duration type 2 diabetes: A randomized, controlled, 10-year follow-up trial. Journal of Diabetes and its Complications. 31(8). 1286–1292. 11 indexed citations
11.
Mu, Yiming, Changyu Pan, Uwe Hehnke, et al.. (2016). Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes. Diabetes Research and Clinical Practice. 124. 48–56. 13 indexed citations
12.
Shi, Xiaoguang, Cheng Han, Jinyuan Mao, et al.. (2015). Optimal and Safe Upper Limits of Iodine Intake for Early Pregnancy in Iodine-Sufficient Regions: A Cross-Sectional Study of 7190 Pregnant Women in China. The Journal of Clinical Endocrinology & Metabolism. 100(4). 1630–1638. 188 indexed citations
13.
Wang, Cong, et al.. (2015). Associations among glycemic excursions, glycated hemoglobin and high-sensitivity C-reactive protein in patients with poorly controlled type 2 diabetes mellitus. Experimental and Therapeutic Medicine. 10(5). 1937–1942. 6 indexed citations
14.
Wang, Yongbo, Jinghong Wang, & Jianling Du. (2014). Research progress of cystatin C in diabetes mellitus and its vascular complications. Zhonghua neifenmi daixie zazhi. 30(10). 859–861. 1 indexed citations
15.
16.
Wang, Qiuming, Jianling Du, Zhijun Duan, et al.. (2013). Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation. World Journal of Gastroenterology. 19(19). 2921–2934. 29 indexed citations
17.
Li, Chenyan, Zhongyan Shan, Jinyuan Mao, et al.. (2013). Assessment of Thyroid Function During First-Trimester Pregnancy: What Is the Rational Upper Limit of Serum TSH During the First Trimester in Chinese Pregnant Women?. The Journal of Clinical Endocrinology & Metabolism. 99(1). 73–79. 172 indexed citations
18.
Zhao, Yin, Lili Men, Rongchong Huang, et al.. (2013). Effects of selenoprotein S on oxidative injury in human endothelial cells. Journal of Translational Medicine. 11(1). 287–287. 28 indexed citations
19.
Hao, Min, Shuyuan Li, Changkai Sun, et al.. (2011). Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro. European Journal of Pharmacology. 654(3). 320–325. 28 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oleg Tsuprykov Breakdown of academic impact, for papers by Marina Shargorodsky Breakdown of academic impact, for papers by Tiziana Filardi Breakdown of academic impact, for papers by Carl V. Felton Breakdown of academic impact, for papers by Tiina Solakivi Breakdown of academic impact, for papers by Yong‐Ki Min Breakdown of academic impact, for papers by Clarice Kazue Fujihara Breakdown of academic impact, for papers by Antonysunil Adaikalakoteswari Breakdown of academic impact, for papers by P. Fumelli Breakdown of academic impact, for papers by E. Delvin
Rankless by CCL
2026